Review of unwanted actions of cannabis and THC

Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential

Volumn , Issue , 2013, Pages 233-248

  Grotenhermen, Franjo ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85071764775     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (33)

1. Abel EL. Marihuana and sex. A critical survey. Drug and Alcohol Dependence 1981;8(1):1-22
2. Agurell S. Halldin M. Lindgren JE. Ohlsson A. Widman M. Gillespie H. Hollister L. Pharmacokinetics and metabolism of delta-I-tetrahydrocannabinol and other cmmabinoids with emphasis on man. Pharmacological Rcvicvv's 1986; 38(1):21-43
3. Campbell DB. Extrapolation from animals to man. The integration of pharmacokinetics and pharmacodynamics. Annals of the New Yark Academy of Sciences 1996;801:116-135
4. Chan PC, Sills RC, Braun AG, Haseman JK, Bucher JR. Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3Fl mice. Fundamental and Applied Toxicology 1996;30(1): 109-117
5. Chopra GS, Jandu BS. Psychodinical effects of long-term marijuana use in 275 Indian chronic users. A comparative assessment of effects in Indian and USA users. Annals of the New York Academy afSciences 1976;282:95-108
6. Cohen S. Cannabis and sex: Multifaceted paradoxes. Journal of Psychoactive Drugs 1982; 14(1-2):55-58
7. Di Franco MJ. Shephard HW. Hunter DJ. Tosteson TD. Ascher MS. The lack of association of marijuana and other recreational dmgs with progression to AIDS in the San Francisco Men's Health Study. Annals of Epidemiology 1996;6(4):283-289
8. Dreher MC, Nugent K, Hudgins R. Prenatal marijuana exposure and neonatal outcomes in Jamaica: An ethnographic study. Pediatrics 1994;93(2):254-260
9. Grotenhermen F. Phannacological and toxicological basis of THC limits for food. In Grotenhermen F, Karus M, Lohmeyer D, eds. Hemp Foods and THe Levels: A scientifh' assessment. Sebastopol, CA: Hemptech, 1998
10. Hall W, Solowij N, Lemon J. The health and psychological consequences of cannabis use. Canberra: Commonwealth Department of Human Services and Health, Monograph Series No. 25, 1994
11. Hall W, Room R, Bondy S. Comparing the health and psychological risks of alcohol, cannabis, nicotine and opiate use. In Kalant H, Corrigan W, Hall W, Srnmt R, eds. The health effects of cannabis, Toronto: Addiction Research Foundation, 1999, pp. 477-508
12. Hansel R. Cannabis. In von Bruchhausen F, ed. Hagers Handbuch der pharmazcutischen Praxis. Bd. 4, Drogen: A-D. Berlin/Heidelberg/New York: Springer, 1992
13. Harvey OJ, Brown NK. Comparative in vitro metabolism of the cannabinoids. Pharmacology, Biochemistry and Behavior 1991;40(3):533-540
14. Hembree WC, Nahas GG, Zeidenberg P, Huang HF. Changes in human spermatozoa associated with high dose marihuana smoking. Advances in the Biosciences 1978;22-23:429-439
15. Hemminki K, Vineis P. Extrapolation of the evidence on teratogenicity of chemicals between humans and experimental animals: Chemicals other than drugs. Teratogenesis, Carcinogenesis, and Mutagenesis 1985; 5(4):251-318
16. Hollister LE, Reaven GM. Delta-9-tetrahydrocannabinol and glucose tolerance. Clinical Pharmacology and Therapeutics 1974;16(2):297-302
17. Hollister LE. Health aspects of cannabis. Pharmacological Reviews 1986; 38(1): 1-20
18. House of Lords Select Committee on Science and Technology. Cannabis: The scientific and medical evidence. London: The Stationery Office, 1998
19. Joesoef MR. Beral V. Aral SO. Rolfs RT. Cramer DW. Fertility and use of cigarettes. alcohol. marijuana. and cocaine. Annals of Epidemiology 1993;3( 1 ):592-594
20. Joy JE, Watson SJ, Benson JA, eds. Marijuana and medicine: Assessing the science base. Washington, DC: Institute of Medicine, National Academy Press, 1999
21. Kaslow RA. Blackwelder WC. Ostrow DG. Yerg D. Palenicek J. Coulson AH, Yaldiserri RO. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-I-positive individuals. A report from the Multicenter AIDS Cohort Study.Tournai of the American Medical Association 1989;261 (23):3424-3429
22. Kleiber D, Soellner R, Tossmann P. Cannahiskonswn in del' Bundesrepllhlik Deutschland: Entlvicklungstendenzen, Konsummuster und Einflubfaktoren. Bonn: Bundesministerium fill Gesundheit, 1997
23. Koff We. Marijuana and sexual activity. Journal of Sex Research 1974; 10(3): 194-204
24. Lyketsos CG, Garrett E, Liang K-Y, Anthony Jc. Cannabis use and cognitive decline in persons under 65 years of age. American.TournaI of Epidemiology 1999; 149(9):794-800
25. Mueller BA, Daling JR, Weiss NS, Moore DE. Recreational drug use and the risk of primary infertility. Epidemiology 1990;1(3):195-200
26. Roques B. Problemes posees par la dangerosite des drogues. Rapport du professeur Bernhard Roques ail Secretaire d' Etat it la Sante. [A report to the French Ministry of Health]. Paris, 1998
27. Schnelle M, Grotenhennen P, Reif M, Gorter RW. Ergebnisse einer stand ardisierten Umfrage zur medizinischen Yerwendung von Cannabisprodukten im deutschen Sprachraul1l [Results of a standardized survey on the medical use of cannabis products in the GeITIlan-speaking area]. Forschende Komplementiirmedizin Research in Complementary Medicine 1999;6(Suppl 3) 28-36
28. Sidney S, Beck JE, Tekawa IS, QuesenbelTY cr, Friedman GO. Marijuana use and mortality. American.Tournai of Public Health 1997;87(4):585-590
29. Thompson GR, Rosenkrantz H, Schaeppi UH, Braude Me. Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys. Toxicology and Applied Pharmacology 1973;25(3):363-372
30. Tindall B, Cooper DA, Donovan B, Barnes T, Philpot CR, Gold J, Penny R. The Sydney AIDS Project: Development of acquired immunodeficiency syndrome in a group of HIV seropositive homosexual men. Australian and New Zealand JournalofMedicine 1988;18(1):8-15
31. Whitfield RM, Bechtel LM, Starich GH. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy. Alcoholism, Clinical and Experimental Research 1997;21(1):122-127
32. World Health Organization. Cannabis: A health perspective and research agenda. Geneva Division of Mental Health and Substance Abuse, WHO, 1997
33. Zimmerman AM, Bruce WR, Zimmerman S. Effects of cannabinoids on sperm morphology. Pharmacology 1979;18(3): 143-148